About
This medication combines Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin, a biguanide, to comprehensively improve glycemic control in adults with type 2 diabetes mellitus. Sitagliptin works by increasing the levels of incretin hormones (GLP-1 and GIP), which enhance glucose-dependent insulin secretion from pancreatic beta cells and suppress glucagon secretion from alpha cells, thereby reducing hepatic glucose output. Metformin, on the other hand, primarily reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity in peripheral tissues. The synergistic action of these two agents addresses multiple pathophysiological aspects of type 2 diabetes, including impaired insulin secretion and insulin resistance, leading to more effective and sustained blood glucose lowering than either drug alone.
Uses
- Management of type 2 diabetes mellitus.
- Improvement of glycemic control.
- Reduction of HbA1c levels.
- Used as an adjunct to diet and exercise.
Directions For Use
Take this medication orally, usually twice daily with meals, as directed by your physician, to minimize gastrointestinal side effects.
Benefits
- Effective blood glucose control.
- Improved insulin secretion.
- Reduced hepatic glucose production.
- Enhanced insulin sensitivity.
- Generally weight-neutral.
- Low risk of hypoglycemia when used alone.
Side Effects
- Nausea
- Diarrhea
- Abdominal pain
- Headache
- Upper respiratory tract infection
- Sore throat
- Pancreatitis (rare, but serious)
- Joint pain
- Allergic reactions (rash, hives)
- Lactic acidosis (rare, but serious, due to Metformin)
- Vitamin B12 deficiency (with long-term Metformin use)
- Metallic taste
Safety Measures
- Alcohol - Avoid excessive alcohol consumption as it can increase the risk of lactic acidosis, especially with Metformin, and may also increase the risk of hypoglycemia.
- Pregnancy - Generally not recommended during pregnancy. Consult your doctor, as alternative treatments may be necessary to manage diabetes safely during this period.
- Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk. Discuss with your healthcare provider.
- Liver - Use with caution in patients with liver impairment, as it may increase the risk of lactic acidosis (Metformin) and affect drug metabolism. Regular monitoring is advised.
- Kidney - Contraindicated in severe renal impairment due to the risk of lactic acidosis (Metformin) and reduced efficacy/increased risk of adverse effects (Sitagliptin). Dose adjustment is required for moderate impairment.
- Lung - Use with caution in patients with severe lung conditions, as these may predispose to hypoxia and increase the risk of lactic acidosis.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!